Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2

RF Butterworth - Frontiers in Neuroscience, 2023 - frontiersin.org
Advent of the acute respiratory coronavirus SARS-CoV-2 has resulted in the search for novel
antiviral agents and in the repurposing of existing agents with demonstrated efficacy against …

Potential for the repurposing of adamantane antivirals for COVID-19

RF Butterworth - Drugs in R&D, 2021 - Springer
Several adamantanes have established actions against coronaviruses. Amantadine,
rimantadine, bananins and the structurally related memantine are effective against human …

Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment

K Rejdak, P Grieb - Multiple sclerosis and related disorders, 2020 - Elsevier
Facing the outbreak of coronavirus disease 2019 (COVID-19) pandemic, there is an urgent
need to find protective or curable drugs to prevent or to stop the course of the coronavirus …

Aminoadamantanes: from treatment of Parkinson's and Alzheimer's disease to symptom amelioration of long COVID-19 syndrome?

T Müller, P Riederer, W Kuhn - Expert Review of Clinical …, 2023 - Taylor & Francis
Introduction The aminoadamantanes amantadine and memantine are well known. They
mainly act as N-methyl-D-aspartate antagonists. Areas covered The antiviral drug …

Amantadine in unvaccinated patients with early, mild to moderate COVID‐19: A randomized, placebo‐controlled, double‐blind trial

K Rejdak, P Fiedor, R Bonek, J Łukasiak… - European Journal of …, 2024 - Wiley Online Library
Background and purpose Adamantanes were listed as an interesting option as an early
intervention against COVID‐19. We aimed to evaluate the effectiveness of amantadine in …

Effect of pre-exposure use of amantadine on COVID-19 infection: a hospital-based cohort study in patients with Parkinson's disease or multiple sclerosis

WA Kamel, MI Kamel, A Alhasawi, S Elmasry… - Frontiers in …, 2021 - frontiersin.org
Background: Amantadine has been proposed to inhibit E-channel conductance in
reconstituted lipid bilayers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

[HTML][HTML] The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV …

K Rejdak, P Fiedor, R Bonek, A Goch… - Contemporary Clinical …, 2022 - Elsevier
Background COVID-19, a disease caused by infection with the SARS-CoV-2 virus, is
asymptomatic or mildly symptomatic in most cases. Some patients, usually burdened with …

Anti-SARS-CoV-2 activity of adamantanes in vitro and in animal models of infection

SY Lim, Z Guo, P Liu, LGA McKay, N Storm, A Griffiths… - Covid, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) has had devastating effects worldwide, with
particularly high morbidity and mortality in outbreaks on residential care facilities …

Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2

A Cortés-Borra, GE Aranda-Abreu - Pharmacological Reports, 2021 - Springer
Background Amantadine is a drug that can help in the prevention of SARS-CoV-2
symptomatology, as has been demonstrated in observational clinical studies. Methods We …

[PDF][PDF] Does amantadine have a protective effect against COVID-19?

AC Borra - Neurologia i Neurochirurgia Polska, 2020 - journals.viamedica.pl
The SARS-CoV-2 pandemic is causing the scientific community to look for the best treatment
to fight the virus. Studies are being carried out worldwide with this purpose looking into …